Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Genome Editing
5:15
CD33 CRISPR/Cas9 gene-edited donor allograft in patients with AML at risk of relapse post-HSCT
John DiPersio
• 21 Feb 2023
2:52
The safety and efficacy of UCART123v1.2 in R/R AML: results from AMELI-01
David Sallman
• 11 Dec 2022
2:04
Targeting WT1 peptides for TCR-based AML therapy
Chiara Bonini
• 1 Apr 2022
1:46
TCR redirected T cells for cancer therapy
Chiara Bonini
• 1 Apr 2022
0:55
The use of CRISPR-Cas9 technology in the development of T cell therapies
Alessio Nahmad
• 31 Mar 2022
1:54
Overexpression of the LBTR gene to optimize T cell proliferation
Mateusz Legut
• 31 Mar 2022
2:17
Accelerating the identification of clinically relevant T cell therapies
Elvira D’Ippolito
• 31 Mar 2022
3:31
Novel approaches in lymphocyte engineering
Elvira D’Ippolito
• 31 Mar 2022
2:57
Adapting cell therapies to solid tumors
Nina Bauer
• 26 Jan 2022
1:47
The advantages and applications of CRISPR-Cas 9
Nina Bauer
• 27 Jan 2022
1:11
Improving cell therapy manufacturing capabilities
Lavakumar Karyampudi
• 27 Jan 2022
1:57
MOMENTUM: ARU-1801 in sickle cell disease
Will Chou
• 26 Jan 2022
2:26
ARU-1801, a novel lentiviral gene therapy for SCD
Will Chou
• 27 Jan 2022
0:38
Looking forward to Advanced Therapies Week 2022
Janet Lynch Lambert
• 26 Jan 2022
2:56
Non-viral gene delivery & gene editing: highlights from ESGCT
Ralf Schmid
• 16 Nov 2021
3:06
CAR-Tregs for the treatment of systemic lupus erythematosus
Chiara Bonini
• 22 Nov 2021
1
2
3
Next